These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4197888)

  • 41. Efficacy of purified lactonase and ciprofloxacin in preventing systemic spread of Pseudomonas aeruginosa in murine burn wound model.
    Gupta P; Chhibber S; Harjai K
    Burns; 2015 Feb; 41(1):153-62. PubMed ID: 25015706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low mortality in burned patients in a Pseudomonas vaccine trial.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1978 Aug; 2(8086):401-3. PubMed ID: 79764
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pyocyaneus infection of burn wounds].
    Kolker II; Grishina IA; Akatova NS; Smirnova NE; Panova IuM
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Mar; (3):52-6. PubMed ID: 404810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of human amniotic membranes on the bacteria population of infected rat burns.
    Robson MC; Krizek TJ
    Ann Surg; 1973 Feb; 177(2):144-9. PubMed ID: 4633388
    [No Abstract]   [Full Text] [Related]  

  • 45. Role of motility and flagellin glycosylation in the pathogenesis of Pseudomonas aeruginosa burn wound infections.
    Arora SK; Neely AN; Blair B; Lory S; Ramphal R
    Infect Immun; 2005 Jul; 73(7):4395-8. PubMed ID: 15972536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spontaneous calcaneal fracture after deep heel burns with diabetes.
    Matsumura H; Jimbo Y; Kato T; Imai S
    Burns; 1998 Nov; 24(7):683-6. PubMed ID: 9882072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of transforming growth factor-beta neutralization on survival and bacterial clearance in a murine model of Pseudomonas aeruginosa burn wound infection.
    Huang Z; Pereira C; Toliver-Kinsky T; Murphey ED; Varma TK; Lin CY; Herndon DN; Sherwood ER
    J Burn Care Res; 2006; 27(5):682-7. PubMed ID: 16998401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical features and pathology of burns.
    Sørensen B; Thomsen M
    Antibiot Chemother (1971); 1989; 42():97-102. PubMed ID: 2688549
    [No Abstract]   [Full Text] [Related]  

  • 49. Major Transcriptome Changes Accompany the Growth of Pseudomonas aeruginosa in Blood from Patients with Severe Thermal Injuries.
    Kruczek C; Kottapalli KR; Dissanaike S; Dzvova N; Griswold JA; Colmer-Hamood JA; Hamood AN
    PLoS One; 2016; 11(3):e0149229. PubMed ID: 26933952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical evaluation of Pseudomonas hyperimmune globulin.
    Jones CE; Alexander JW; Fisher M
    J Surg Res; 1973 Feb; 14(2):87-96. PubMed ID: 4632770
    [No Abstract]   [Full Text] [Related]  

  • 51. Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB/c mice in a novel chronic wound model.
    Trøstrup H; Thomsen K; Christophersen LJ; Hougen HP; Bjarnsholt T; Jensen PØ; Kirkby N; Calum H; Høiby N; Moser C
    Wound Repair Regen; 2013; 21(2):292-9. PubMed ID: 23437978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitation of Pseudomonas aeruginosa in wound biopsy samples: from bacterial culture to rapid 'real-time' polymerase chain reaction.
    Pirnay JP; De Vos D; Duinslaeger L; Reper P; Vandenvelde C; Cornelis P; Vanderkelen A
    Crit Care; 2000; 4(4):255-61. PubMed ID: 11056755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Typing of pseudomonas aeruginosa in patients injured by burns (author's transl)].
    Zellner PR; Metzger E
    Med Klin; 1974 Feb; 69(8):346-9. PubMed ID: 4207880
    [No Abstract]   [Full Text] [Related]  

  • 54. Re: Pseudomonas aeruginosa isolates from burn patients in the Northwest of Pakistan.
    Arya SC; Agarwal N; Agarwal S
    Burns; 2010 Aug; 36(5):739-40. PubMed ID: 20071094
    [No Abstract]   [Full Text] [Related]  

  • 55. Pivotal advance: glycyrrhizin restores the impaired production of beta-defensins in tissues surrounding the burn area and improves the resistance of burn mice to Pseudomonas aeruginosa wound infection.
    Yoshida T; Yoshida S; Kobayashi M; Herndon DN; Suzuki F
    J Leukoc Biol; 2010 Jan; 87(1):35-41. PubMed ID: 19843573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Growth of Pseudomonas aeruginosa in normal and burned skin extract: role of extracellular proteases.
    Cicmanec JF; Holder IA
    Infect Immun; 1979 Aug; 25(2):477-83. PubMed ID: 114486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Electron microscopic study of the dynamics of experimental pyocyaneus pneumonia in the presence of severe burn injury].
    Vtiurin BV; Kaem RI
    Arkh Patol; 1977; 39(12):45-51. PubMed ID: 414698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Bacteriological and pathomorphological control of the effectiveness of the therapy of experimental pyocyanic burn infection].
    Girich AF; Rudzit EA; Starkov MV; Iakovlev VP
    Antibiotiki; 1980 Aug; 25(8):589-94. PubMed ID: 7406471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mouse Model of Burn Wound and Infection: Thermal (Hot Air) Lesion-Induced Immunosuppression.
    Calum H; Høiby N; Moser C
    Curr Protoc Mouse Biol; 2017 Jun; 7(2):77-87. PubMed ID: 28628217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Drug sensitivity of Pseudomonas aeruginosa isolated from burn wounds during 1985/1986 and its serologic types].
    Ziółkowski G; Dudzińska G; Sakiel S
    Pol Tyg Lek; 1988 Dec; 43(49):1596-8. PubMed ID: 3151376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.